Aktis Oncology, Inc. (AKTS) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Aktis Oncology, Inc. (AKTS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.11B, listed on NASDAQ, employing roughly 79 people, carrying a beta of 1.10 to the broader market. Aktis Oncology, Inc. Led by Matthew Roden, public since 2026-01-09.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for AKTS as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →